Identification, purification, and radioimmunoassay of NB/70K, a human ovarian tumor-associated antigen
- PMID: 6163521
Identification, purification, and radioimmunoassay of NB/70K, a human ovarian tumor-associated antigen
Abstract
NB/70K, a tumor-associated antigen of human ovarian epithelial tumor Fraction OCA, has been purified and identified as a glycoprotein which is stable in 0.6 M perchloric acid, binds to concanavalin A, and migrates electrophoretically with alpha-like mobility in barbital-buffered agarose at pH 8.6. NB/70K does not appear to contain normal serum, normal ovary, normal lung, or carcinoembryonic antigen-like cross-reacting antigenic determinants as measured by radioimmunoassay. NB/70K has been purified from ovarian antigen Fraction OCA by chromatography on gamma-globulin coupled to Sepharose 4B and by elution from acrylamide gels. NB/70K migrates as a single band with an apparent molecular weight of 70,000 in sodium dodecyl sulfate:acrylamide gel electrophoresis. A rabbit antibody raised against NB/70K was able to precipitate a polypeptide with a molecular weight of 70,000 as visualized by autoradiography of sodium dodecyl sulfate:acrylamide gels. A radioimmunoassay has been developed for measuring NB/70K activity, using Staphylococcus aureus protein A as a precipitating agent.
Similar articles
-
Monoclonal antibodies against human ovarian tumor associated antigen NB/70K: preparation and use in a radioimmunoassay for measuring NB/70K in serum.Cancer Immunol Immunother. 1986;21(3):217-25. doi: 10.1007/BF00199365. Cancer Immunol Immunother. 1986. PMID: 2421899 Free PMC article.
-
Clinical correlations of ovarian cancer antigen NB/70K: a preliminary report.Obstet Gynecol. 1985 May;65(5):710-4. Obstet Gynecol. 1985. PMID: 3856794
-
Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas.Cancer Res. 1986 Dec;46(12 Pt 1):6143-8. Cancer Res. 1986. PMID: 2430690
-
The development of a double-antibody radioimmunoassay for detecting ovarian tumor-associated antigen fraction OCA in plasma.Am J Obstet Gynecol. 1978 Aug 1;131(7):780-7. doi: 10.1016/0002-9378(78)90247-8. Am J Obstet Gynecol. 1978. PMID: 686071
-
Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigens.Obstet Gynecol Surv. 1984 Jun;39(6):346-60. Obstet Gynecol Surv. 1984. PMID: 6203071 Review.
Cited by
-
Role of CD47 in tumor immunity: a potential target for combination therapy.Sci Rep. 2022 Jun 13;12(1):9803. doi: 10.1038/s41598-022-13764-3. Sci Rep. 2022. PMID: 35697717 Free PMC article.
-
Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma.Am J Transl Res. 2017 Jun 15;9(6):2901-2910. eCollection 2017. Am J Transl Res. 2017. PMID: 28670378 Free PMC article.
-
Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody.Cancer Immunol Immunother. 1992;35(1):19-26. doi: 10.1007/BF01741050. Cancer Immunol Immunother. 1992. PMID: 1611619 Free PMC article.
-
Monoclonal antibodies against human ovarian tumor associated antigen NB/70K: preparation and use in a radioimmunoassay for measuring NB/70K in serum.Cancer Immunol Immunother. 1986;21(3):217-25. doi: 10.1007/BF00199365. Cancer Immunol Immunother. 1986. PMID: 2421899 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical